AnaptysBio Adds More Shares, Raises $75M in Stock Market Debut
Xconomy
JANUARY 26, 2017
biotech company to go public this year, raising $75 million in an IPO intended to finance development of antibody-based drugs for inflammatory disorders. As has been the case for biotechs over the past year , insiders helped Anaptys get to the public market. AnaptysBio is the first U.S. Stockholders who had invested in the.
40 
Let's personalize your content